The Bahrain Oncology Center now is among the first in the world to offer Casgevy (exagamglogene autotemcel), an approved…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Bluebird Bio has announced it’s completed collecting cells from the first sickle cell disease (SCD) patient receiving the…
Having male adolescents with sickle cell disease (SCD) undergo fertility testing by semen analysis may not be feasible if…
Novartis is recalling its sickle cell disease (SCD) treatment Adakveo (crizanlizumab) in the U.K., after the nation’s drug…
Heavier menstrual bleeding and pain during menstrual periods appear to be prevalent among adolescents and young women with sickle…
Skin grafts can ease pain associated with leg ulcers and improve wound healing in people with sickle cell disease…
A portrait of 4-year-old Kynnedi Sturges, who is living with sickle cell disease (SCD) in Camden, Arkansas, was unveiled…
The Georgia State University Research Foundation has received a grant from the Centers for Disease Control and Prevention (CDC)…
Corticosteroids taken during pregnancy are a risk factor for more severe vaso-occlusive crises (VOCs) in women with sickle…
The U.S. Food and Drug Administration (FDA) has cleared for use Trinity Biotech’s Premier Resolution System, an automated…